Gene · 84433
Papers2,534
Newest first. Swiss-Prot's references are curated; PubTator's text mining finds papers that name the gene, not always ones about it.
161 to 180 of 2,534
Download this page as JSON| Title | Journal | Year | PMID | Found by | Source |
|---|---|---|---|---|---|
| Dominant-negative CARD11 loss-of-function variant presenting with hypereosinophilic syndrome. | Pediatr Allergy Immunol | 2023 | 38010008 | PubTator, text mining | PubMed |
| New Perspectives about Drug Candidates Targeting HTLV-1 and Related Diseases. | Pharmaceuticals (Basel) | 2023 | 38004412 | PubTator, text mining | PubMed |
| Elevated IgE Levels-An Allergy or an Underlying Inborn Error of Immunity in Children with Recurrent Infections? | Antibodies (Basel) | 2023 | 37987248 | PubTator, text mining | PubMed |
| Progressive Multifocal Leukoencephalopathy in Systemic Lupus Erythematosus: A Consequence of Patient-Intrinsic or -Extrinsic Factors? | J Clin Med | 2023 | 37959410 | PubTator, text mining | PubMed |
| IRAK-4 inhibition: emavusertib for the treatment of lymphoid and myeloid malignancies. | Front Immunol | 2023 | 37954584 | PubTator, text mining | PubMed |
| Exploring the cell-free total RNA transcriptome in diffuse large B-cell lymphoma and primary mediastinal B-cell lymphoma patients as biomarker source in blood plasma liquid biopsies. | Front Oncol | 2023 | 37954086 | PubTator, text mining | PubMed |
| Autoantibodies against type I IFNs in humans with alternative NF-κB pathway deficiency. | Nature | 2023 | 37938781 | PubTator, text mining | PubMed |
| Transcriptome profiling of regulatory T cells from children with transient hypogammaglobulinemia of infancy. | Clin Exp Immunol | 2023 | 37936298 | PubTator, text mining | PubMed |
| Inhibition of glutaminase-1 in DLBCL potentiates venetoclax-induced antitumor activity by promoting oxidative stress. | Blood Adv | 2023 | 37934892 | PubTator, text mining | PubMed |
| TCR Pathway Mutations in Mature T Cell Lymphomas. | J Immunol | 2023 | 37931208 | PubTator, text mining | PubMed |
| Survival benefit and biomarker of PD-1 inhibitor combination therapy in first-line of advanced biliary tract cancer: A retrospective study. | Cancer Med | 2023 | 37930138 | PubTator, text mining | PubMed |
| Clonal Relationship and Mutation Analysis in Lymphoplasmacytic Lymphoma/Waldenström Macroglobulinemia Associated With Diffuse Large B-cell Lymphoma. | Hemasphere | 2023 | 37928625 | PubTator, text mining | PubMed |
| DOK3 promotes atopic dermatitis by enabling the phosphatase PP4C to inhibit the T cell signaling mediator CARD11. | Sci Signal | 2023 | 37906628 | PubTator, text mining | PubMed |
| Clinicopathologic and mutational profiles of primary breast diffuse large B cell lymphoma in a male patient: case report and literature review. | World J Surg Oncol | 2023 | 37884941 | PubTator, text mining | PubMed |
| A Specialized Epithelial Cell Type Regulating Mucosal Immunity and Driving Human Crohn's Disease. | bioRxiv | 2023 | 37873404 | PubTator, text mining | PubMed |
| High PDL1/PDL2 gene expression correlates with worse outcome in primary mediastinal large B-cell lymphoma. | Blood Adv | 2023 | 37862676 | PubTator, text mining | PubMed |
| Cellular vimentin regulates the infectivity of Newcastle disease virus through targeting of the HN protein. | Vet Res | 2023 | 37848995 | PubTator, text mining | PubMed |
| Chinese expert consensus on Bruton tyrosine kinase inhibitors in the treatment of B-cell malignancies. | Exp Hematol Oncol | 2023 | 37845755 | PubTator, text mining | PubMed |
| Illuminating (HTLV-1)-induced adult T-cell leukemia/lymphoma transcriptomic signature: A systems virology approach. | Virus Res | 2023 | 37832654 | PubTator, text mining | PubMed |
| Analysis of shared ceRNA networks and related-hub genes in rats with primary and secondary photoreceptor degeneration. | Front Neurosci | 2023 | 37811327 | PubTator, text mining | PubMed |
gene-search-2026-11-11-0.2.0
Sources 12
- ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- EMBL-EBI's patent proteinsNo added restrictions. Attribution expected
- GenBank's patent filesNo restrictions from NCBI. Submitters may hold rights
- HGNCCC0
- NCBI GenePublic domain (US government)
- NIH's project files and grant-paper linksPublic domain
- Open TargetsCC0 1.0
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- EMBL-EBI's patent proteinsEMBL-EBI's patent protein files from the EPO, JPO, KIPO and USPTO. EMBL-EBI: "EMBL-EBI itself places no additional restrictions on the use or redistribution of the data available via its Data Resources and Tools other than those provided by the original data owners" and "EMBL-EBI expects attribution (e.g. in publications, services or products) for the use of any of its Data Resources and Tools." Read on 11 Nov 2026 at https://www.ebi.ac.uk/about/terms-of-use
- GenBank's patent filesGenBank's patent files. NCBI: "NCBI places no restrictions on the use or distribution of the GenBank data. However, some submitters may claim patent, copyright, or other intellectual property rights in all or a portion of the data they have submitted." Read on 11 Nov 2026 at https://www.ncbi.nlm.nih.gov/genbank/about/
- HGNCCC0: https://www.genenames.org/about/license/
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH's project files and grant-paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this list from software.
Twenty rows a page, as JSON. No key.
GET https://conductscience.org/api/genes/v1/84433/papers?page=9